中华皮肤科杂志 ›› 2018, Vol. 51 ›› Issue (10): 711-714.doi: 10.3760/cma.j.issn.0412-4030.2018.10.001
• 专家论坛 • 下一篇
王刚
收稿日期:2018-04-24
修回日期:2018-05-26
出版日期:2018-10-15
发布日期:2018-10-03
通讯作者:
王刚
E-mail:xjwgang@fmmu.edu.cn
WANG Gang
Received:2018-04-24
Revised:2018-05-26
Online:2018-10-15
Published:2018-10-03
Contact:
WANG Gang
E-mail:xjwgang@fmmu.edu.cn
摘要： 在众多银屑病发病机制研究中，T细胞主导免疫微环境紊乱已被广泛认可。大量中性粒细胞在表皮聚集，形成Munro或Kogoj微脓疡，是银屑病典型病理特征之一，但其在银屑病免疫紊乱中发挥的作用却尚未明确。近十余年，关于中性粒细胞研究的科学发现引起了研究者对这群寿命较短的固有免疫细胞的兴趣，对其在银屑病发病机制中的作用进行了深入的探讨。
王刚. 中性粒细胞：银屑病研究新热点[J]. 中华皮肤科杂志, 2018, 51(10): 711-714.
WANG Gang. Neutrophils: a new hotspot in psoriasis research[J]. Chinese Journal of Dermatology, 2018, 51(10): 711-714.
| ［1］ | Boehncke WH, Schön MP. Psoriasis［J］. Lancet, 2015,386（9997）:983⁃994. doi: 10.1016/S0140⁃6736（14）61909⁃7.<br /> |
| ［2］ | Wolberink EA, Peppelman M, van de Kerkhof PC, et al. Establishing the dynamics of neutrophil accumulation in vivo by reflectance confocal microscopy［J］. Exp Dermatol, 2014,23（3）:184⁃188. doi: 10.1111/exd.12345.<br /> |
| ［3］ | Perera GK, Di MP, Nestle FO. Psoriasis［J］. Annu Rev Pathol, 2012,7:385⁃422. doi: 10.1146/annurev⁃pathol⁃011811⁃132448.<br /> |
| ［4］ | Nicolás⁃Ávila JÁ, Adrover JM, Hidalgo A. Neutrophils in homeo⁃stasis, immunity, and cancer［J］. Immunity, 2017,46（1）:15⁃28. doi: 10.1016/j.immuni.2016.12.012.<br /> |
| ［5］ | Ogawa E, Sato Y, Minagawa A, et al. Pathogenesis of psoriasis and development of treatment［J］. J Dermatol, 2018,45（3）:264⁃272. doi: 10.1111/1346⁃8138.14139.<br /> |
| ［6］ | Uribe⁃Herranz M, Lian LH, Hooper KM, et al. IL⁃1R1 signaling facilitates Munro′s microabscess formation in psoriasiform imiquimod⁃induced skin inflammation［J］. J Invest Dermatol, 2013,133（6）:1541⁃1549. doi: 10.1038/jid.2012.512.<br /> |
| ［7］ | Steffen S, Abraham S, Herbig M, et al. Toll⁃like receptor⁃mediated upregulation of CXCL16 in psoriasis orchestrates neutrophil activation［J］. J Invest Dermatol, 2018,138（2）:344⁃354. doi: 10.1016/j.jid.2017.08.041.<br /> |
| ［8］ | Foster AM, Baliwag J, Chen CS, et al. IL⁃36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin［J］. J Immunol, 2014,192（12）:6053⁃6061. doi: 10.4049/jimmunol.1301 481.<br /> |
| ［9］ | Amulic B, Cazalet C, Hayes GL, et al. Neutrophil function: from mechanisms to disease［J］. Annu Rev Immunol, 2012,30:459⁃489. doi: 10.1146/annurev⁃immunol⁃020711⁃074942.<br /> |
| ［10］ | Minakawa S, Kaneko T, Matsuzaki Y, et al. Psoriasis area and severity index is closely related to serum C⁃reactive protein level and neutrophil to lymphocyte ratio in Japanese patients［J］. J Dermatol, 2017,44（10）:e236⁃236e237. doi: 10.1111/1346⁃8138. 13942.<br /> |
| ［11］ | Glowacka E, Lewkowicz P, Rotsztejn H, et al. IL⁃8, IL⁃12 and IL⁃10 cytokines generation by neutrophils, fibroblasts and neutrophils⁃fibroblasts interaction in psoriasis［J］. Adv Med Sci, 2010,55（2）:254⁃260. doi: 10.2478/v10039⁃010⁃0037⁃0.<br /> |
| ［12］ | Morizane S, Nomura H, Tachibana K, et al. The synergistic activities of the combination of tumour necrosis factor⁃α, interleukin⁃17A and interferon⁃γ in epidermal keratinocytes［J］.Br J Dermatol, 2018. doi: 10.1111/bjd.16443.<br /> |
| ［13］ | Henry CM, Sullivan GP, Clancy DM, et al. Neutrophil⁃derived proteases escalate inflammation through activation of IL⁃36 family cytokines［J］. Cell Rep, 2016,14（4）:708⁃722. doi: 10.1016/ j.celrep.2015.12.072.<br /> |
| ［14］ | Glennon⁃Alty L, Hackett AP, Chapman EA, et al. Neutrophils and redox stress in the pathogenesis of autoimmune disease［J］. Free Radic Biol Med, 2018,pii:S0891⁃5849（18）30159⁃X. doi: 10.1016/ j.freeradbiomed.2018.03.049.<br /> |
| ［15］ | Dilek N, Dilek AR, Taşkın Y, et al. Contribution of myelo⁃peroxidase and inducible nitric oxide synthase to pathogenesis of psoriasis［J］. Postepy Dermatol Alergol, 2016,33（6）:435⁃439. doi: 10.5114/ada.2016.63882.<br /> |
| ［16］ | Yang X, Yan H, Zhai Z, et al. Neutrophil elastase promotes proliferation of HaCaT cell line and transwell psoriasis organ culture model［J］. Int J Dermatol, 2010,49（9）:1068⁃1074. doi: 10. 1111/j.1365⁃4632.2010.04500.x.<br /> |
| ［17］ | Okubo K, Kamiya M, Urano Y, et al. Lactoferrin suppresses neutrophil extracellular traps release in inflammation［J］. EBioMedicine, 2016,10:204⁃215. doi: 10.1016/j.ebiom.2016.07. 012.<br /> |
| ［18］ | Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense［J］. Trends Immunol, 2009,30（3）:131⁃141. doi: 10.1016/j.it.2008.12.003.<br /> |
| ［19］ | Batycka⁃Baran A, Maj J, Wolf R, et al. The new insight into the role of antimicrobial proteins⁃alarmins in the immunopatho⁃genesis of psoriasis［J］. J Immunol Res, 2014,2014:628289. doi: 10.1155/2014/628289.<br /> |
| ［20］ | Zheng Y, Niyonsaba F, Ushio H, et al. Cathelicidin LL⁃37 induces the generation of reactive oxygen species and release of human alpha⁃defensins from neutrophils［J］. Br J Dermatol, 2007,157（6）: 1124⁃1131. doi: 10.1111/j.1365⁃2133.2007.08196.x.<br /> |
| ［21］ | Shao S, Cao T, Jin L, et al. Increased lipocalin⁃2 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion［J］. J Invest Dermatol, 2016,136（7）:1418⁃1428. doi: 10.1016/j.jid.2016.03.002.<br /> |
| ［22］ | Chiricozzi A, Romanelli P, Volpe E, et al. Scanning the immuno⁃pathogenesis of psoriasis［J］. Int J Mol Sci, 2018,19（1）:179. doi: 10.3390/ijms19010179.<br /> |
| ［23］ | Hagert C, Sareila O, Kelkka T, et al. The macrophage mannose receptor regulate mannan⁃induced psoriasis, psoriatic arthritis, and rheumatoid arthritis⁃like disease models［J］. Front Immunol, 2018,9:114. doi: 10.3389/fimmu.2018.00114.<br /> |
| ［24］ | Xu D, Matsumoto ML, McKenzie BS, et al. TPL2 kinase action and control of inflammation［J］. Pharmacol Res, 2018,129:188⁃193. doi: 10.1016/j.phrs.2017.11.031.<br /> |
| ［25］ | Kim HJ, Roh JY, Jung Y. Eosinophils accelerate pathogenesis of psoriasis by supporting inflammatory milieu that promotes neutrophil infiltration［J］. J Invest Dermatol, 2018,pii:S0022⁃202X（18）31744⁃5. doi: 10.1016/j.jid.2018.03.1509.<br /> |
| ［26］ | Bachelez H. Pustular psoriasis and related pustular skin diseases［J］. Br J Dermatol, 2018,178（3）:614⁃618. doi: 10.1111/bjd.16232.<br /> |
| ［27］ | Johnston A, Xing X, Wolterink L, et al. IL⁃1 and IL⁃36 are dominant cytokines in generalized pustular psoriasis［J］. J Allergy Clin Immunol, 2017,140（1）:109⁃120. doi: 10.1016/j.jaci.2016.08. 056.<br /> |
| ［28］ | Higashi Y, Yamakuchi M, Fukushige T, et al. High⁃fat diet exacerbates imiquimod⁃induced psoriasis⁃like dermatitis in mice［J］. Exp Dermatol, 2018,27（2）:178⁃184. doi: 10.1111/exd.13484.<br /> |
| ［29］ | Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high⁃fat diet through secreted elastase［J］. Nat Med, 2012,18（9）:1407⁃1412. doi: 10.1038/nm. 2885.<br /> |
| ［30］ | Higashi Y, Yamakuchi M, Fukushige T, et al. High⁃fat diet exacerbates imiquimod⁃induced psoriasis⁃like dermatitis in mice［J］. Exp Dermatol, 2018,27（2）:178⁃184. doi: 10.1111/exd.13484.<br /> |
| ［31］ | Naik HB, Natarajan B, Stansky E, et al. Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective obser⁃vational study［J］. Arterioscler Thromb Vasc Biol, 2015,35（12）:2667⁃2676. doi: 10.1161/ATVBAHA.115.306460.<br /> |
| ［32］ | Papayannopoulos V. Neutrophil extracellular traps in immunity and disease［J］. Nat Rev Immunol, 2018,18（2）:134⁃147. doi: 10.1038/nri.2017.105.<br /> |
| ［33］ | Lee KH, Kronbichler A, Park DD, et al. Neutrophil extracellular traps （NETs） in autoimmune diseases: A comprehensive review［J］. Autoimmun Rev, 2017,16（11）:1160⁃1173. doi: 10.1016/j.autrev.2017.09.012.<br /> |
| ［34］ | Knight JS, Carmona⁃Rivera C, Kaplan MJ. Proteins derived from neutrophil extracellular traps may serve as self⁃antigens and mediate organ damage in autoimmune diseases［J］. Front Immunol, 2012,3:380. doi: 10.3389/fimmu.2012.00380.<br /> |
| ［35］ | Tadie JM, Bae HB, Jiang S, et al. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll⁃like receptor 4［J］. Am J Physiol Lung Cell Mol Physiol, 2013,304（5）:L342⁃349. doi: 10.1152/ajplung.00151.2012.<br /> |
| ［36］ | Majewski P, Majchrzak⁃Gorecka M, Grygier B, et al. Inhibitors of serine proteases in regulating the production and function of neutrophil extracellular traps［J］. Front Immunol, 2016,7:261. doi: 10.3389/fimmu.2016.00261.<br /> |
| ［37］ | Zabieglo K, Majewski P, Majchrzak⁃Gorecka M, et al. The inhibitory effect of secretory leukocyte protease inhibitor （SLPI） on formation of neutrophil extracellular traps［J］. J Leukoc Biol, 2015,98（1）:99⁃106. doi:10.1189/jlb.4AB1114⁃543R.<br /> |
| ［38］ | Keijsers R, Hendriks AGM, van Erp PEJ, et al. In vivo induction of cutaneous inflammation results in the accumulation of extra⁃cellular trap⁃forming neutrophils expressing RORgammat and IL⁃17［J］. J Invest Dermatol, 2014,134（5）:1276⁃1284. doi:10.1038/jid.2013.526.<br /> |
| ［39］ | Skrzeczynska⁃Moncznik J, Wlodarczyk A, Banas M, et al. DNA structures decorated with cathepsin G/secretory leukocyte proteinase inhibitor stimulate IFNI production by plasmacytoid dendritic cells［J］. Am J Clin Exp Immunol, 2013,2（2）:186⁃194.<br /> |
| ［40］ | Skrzeczynska⁃Moncznik J, Wlodarczyk A, Zabieglo K, et al. Secretory leukocyte proteinase inhibitor⁃competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: implication for psoriasis［J］. J Immunol, 2012,189（4）:1611⁃1617. doi: 10. 4049/ jimmunol.1103293.<br /> |
| ［41］ | Hu SC, Yu HS, Yen FL, et al. Neutrophil extracellular trap formation is increased in psoriasis and induces human β⁃defensin⁃2 production in epidermal keratinocytes［J］. Sci Rep, 2016,6:31119. doi: 10.1038/srep31119.<br /> |
| ［42］ | Macleod T, Doble R, McGonagle D, et al. Neutrophil elastase⁃mediated proteolysis activates the anti⁃inflammatory cytokine IL⁃36 receptor antagonist［J］. Sci Rep, 2016,6:24880. doi: 10.1038/srep24880.<br /> |
| ［43］ | Ainscough JS, Macleod T, McGonagle D, et al. Cathepsin S is the major activator of the psoriasis⁃associated proinflammatory cyto⁃kine IL⁃36γ［J］. Proc Natl Acad Sci U S A, 2017,114（13）:E2748⁃2748E2757. doi: 10.1073/pnas.1620954114.<br /> |
| ［44］ | Clancy DM, Henry CM, Sullivan GP, et al. Neutrophil extracellular traps can serve as platforms for processing and activation of IL⁃1 family cytokines［J］. FEBS J, 2017,284（11）:1712⁃1725. doi: 10.1111/febs.14075.<br /> |
| ［45］ | Tillack K, Breiden P, Martin R, et al. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses［J］. J Immunol, 2012,188（7）:3150⁃3159. doi: 10.4049/jimmunol.1103414.<br /> |
| ［46］ | Kahlenberg JM, Carmona⁃Rivera C, Smith CK, et al. Neutrophil extracellular trap⁃associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages［J］. J Immunol, 2013,190（3）:1217⁃1226. doi: 10.4049/jimmunol.1202388.<br /> |
| ［47］ | Chrysanthopoulou A, Mitroulis I, Apostolidou E, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts［J］. J Pathol, 2014,233（3）:294⁃307. doi: 10.1002/path. 4359.<br /> |
| ［48］ | Sumida H, Yanagida K, Kita Y, et al. Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod⁃induced psoriasis［J］. J Immunol, 2014,192（9）:4361⁃4369. doi: 10.4049/jimmunol.1302959.<br /> |
| ［49］ | Fujisawa T, Murase K, Okumura Y, et al. Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis［J］. Ther Apher Dial, 2011,15（4）:374⁃378. doi: 10.1111/j.1744⁃9987.2011.00961.x.<br /> |
| ［50］ | Sakanoue M, Takeda K, Kawai K, et al. Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy［J］. Ther Apher Dial, 2013,17（5）:477⁃483. doi: 10.1111/1744⁃9987.12113.<br /> |
| ［51］ | Kanekura T, Seishima M, Honma M, et al. Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: efficacy of a non⁃drug intervention for patients refractory to pharmacologics［J］. J Dermatol, 2017,44（12）:1353⁃1359. doi: 10.1111/1346⁃8138.13975.<br /> |
| ［52］ | JHO H, Schaekel K, Hartl D, et al. Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione⁃ and superoxide⁃dependent manner［J］. Br J Dermatol, 2018,178（1）:207⁃214. doi: 10.1111/bjd.15839.<br /> |
| ［53］ | Mahil SK, Catapano M, Di MP, et al. An analysis of IL⁃36 signature genes and individuals with IL1RL2 knockout mutations validates IL⁃36 as a psoriasis therapeutic target［J］. Sci Transl Med, 2017,9（411）:pii:eaan2514. doi: 10.1126/scitranslmed.aan 2514.<br /> |
| ［54］ | Marto J, Ruivo E, Lucas SD, et al. Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance［J］. Eur J Pharm Biopharm, 2018,127:1⁃11. doi: 10. 1016/j.ejpb.2018.01.011.<br /> |
| ［55］ | Sullivan GP, Henry CM, Clancy DM, et al. Suppressing IL⁃36⁃driven inflammation using peptide pseudosubstrates for neutro⁃phil proteases［J］. Cell Death Dis, 2018,9（3）:378. doi: 10.1038/s41419⁃018⁃0385⁃4.<br /> |
| ［56］ | Yamanaka K, Umezawa Y, Yamagiwa A, et al. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils［J］. J Dermatol, 2014,41（8）:679⁃685. doi: 10.1111/1346⁃8138.12560.<br /> |
| ［57］ | Reich K, Papp KA, Matheson RT, et al. Evidence that a neutrophil⁃keratinocyte crosstalk is an early target of IL⁃17A inhibition in psoriasis［J］. Exp Dermatol, 2015,24（7）:529⁃535. doi: 10.1111/exd.12710.<br /> |
| No related articles found! |
|
